dolutegravir/abacavir/lamivudine fixed-dose combination
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for dolutegravir/abacavir/lamivudine fixed-dose combination, covering 2021-11-22 to 2021-11-22. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV Infection [NA]